Association of CD22 gene polymorphism with susceptibility to limited cutaneous systemic sclerosis

Tissue Antigens

Volumn 69, Issue 3, 2007, Pages 242-249

  Hitomi, Y ^a   Tsuchiya, N ^b   Hasegawa, M ^c   Fujimoto, M ^c   Takehara, K ^c   Tokunaga, K ^a   Sato, S ^d  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^d NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

B cells; CD22; Genetics; Polymorphism; Systemic sclerosis

Indexed keywords

CD19 ANTIGEN; CD22 ANTIGEN;

ADULT; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CD22 GENE; CONTROLLED STUDY; DNA POLYMORPHISM; EXON; FEMALE; GENE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC SCLEROSIS;

ADULT; ANTIGENS, CD19; ANTIGENS, CD22; ASIAN CONTINENTAL ANCESTRY GROUP; B-LYMPHOCYTES; EXONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SCLERODERMA, SYSTEMIC;

EID: 34247894070     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2007.00801.x     Document Type: Article

References (15)

1. Sato S, Fujimoto M, Hasegawa M, Takehara K, Tedder TF. Altered B lymphocyte function induces systemic autoimmunity in systemic sclerosis. Mol Immunol 2004 : 41 : 1123 33.
2. Fujimoto M, Sato S. B lymphocytes and systemic sclerosis. Curr Opin Rheumatol 2005 : 17 : 746 51.
3. St Clair EW, Tedder TF. New prospects for autoimmune disease therapy: B cells on deathwatch. Arthritis Rheum 2006 : 54 : 1 9.
4. Asano N, Fujimoto M, Yazawa N et al. B Lymphocyte signaling established by the CD19/CD22 loop regulates autoimmunity in the tight-skin mouse. Am J Pathol 2004 : 165 : 641 50.
5. Nitschke L, Tsubata T. Molecular interactions regulate BCR signal inhibition by CD22 and CD72. Trends Immunol 2004 : 25 : 543 50.
6. Erickson LD, Tygrett LT, Bhatia SK, Grabstein KH, Waldschmidt TJ. Differential expression of CD22 (Lyb8) on murine B cells. Int Immunol 1996 : 8 : 1121 9.
7. Sato S, Hasegawa M, Fujimoto M, Tedder TF, Takehara K. Quantitative genetic variation in CD19 expression correlates with autoimmunity. J Immunol 2000 : 165 : 6635 43.
8. Saito E, Fujimoto M, Hasegawa M et al. CD19-dependent B lymphocyte signaling thresholds influence skin fibrosis and autoimmunity in the tight-skin mouse. J Clin Invest 2002 : 109 : 1453 62.
9. Tsuchiya N, Kuroki K, Fujimoto M et al. Association of a functional CD19 polymorphism with susceptibility to systemic sclerosis. Arthritis Rheum 2004 : 50 : 4002 7.
10. Hatta Y, Tsuchiya N, Matsushita M, Shiota M, Hagiwara K, Tokunaga K. Identification of the gene variations in human CD22. Immunogenetics 1999 : 49 : 280 6.
11. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980 : 23 : 581 90.
12. den Dunnen J. Nomenclature for the description of sequence variations. http://www.genomic.unimelb.edu.au/mdi/mutnomen/.
13. Ardlie KG, Kruglyak L, Seielstad MS. Patterns of linkage disequilibrium in human genome. Nat Rev Genet 2002 : 3 : 299 309.
14. Duan J, Wainwright MS, Comeron JM et al. Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum Mol Genet 2003 : 12 : 205 16.
15. Cheung VG, Spielman RS, Ewens KG, Weber TM, Morley M, Burdick JT. Mapping determinants of human gene expression by regional and genome-wide association. Nature 2005 : 437 : 1365 9.